Biosyent Financial Overview
Biosyent's market cap is currently C$146.89M. The company's EPS TTM is C$0.23; its P/E ratio is 16.70; and it has a dividend yield of 1.60%. Biosyent is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
